Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials

Published:2015-09-28 Issue:11 Volume:31 Page:1993-2000
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Blonde Lawrence¹,Woo Vincent²,Mathieu Chantal³,Yee Jacqueline⁴,Vijapurkar Ujjwala⁴,Canovatchel William⁴,Meininger Gary⁴

Affiliation:

1. aOchsner Diabetes Clinical Research Unit, Frank Riddick Diabetes Institute, Department of Endocrinology, Ochsner Medical Center, New Orleans, LA, USA

2. bEndocrinology Section, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada

3. cClinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium

4. dJanssen Research & Development LLC, Raritan, NJ, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2015.1082991

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

2. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

3. Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2021-07-19

4. Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies;Diabetes and Vascular Disease Research;2019-05-13

5. Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida;Current Medical Research and Opinion;2018-03-05